GleamWall
中文EN

PETV PetVivo Holdings, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1512922 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-22.5%
TTM net income YoY0.2%
TTM EPS YoY18.9%
Revenue 3-yr CAGR4.4%
Net income 3-yr CAGR—

Margins

Gross margin70.3%
Operating margin-796.7%
Net margin-798.7%
FCF margin-386.1%
EBITDA margin-769.4%

Returns

ROE-433.2%
ROA-235.4%
ROIC (approx.)-424.0%
Asset turnover0.29x

Leverage & solvency

Liabilities / assets107.4%
Debt / equity—
Current ratio0.31x
Interest coverage-394.93x

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio-122.2%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$212,806$337,572$254,715$286,108$303,284$297,500$224,750$583,313
Cost of revenue$16,731$114,255$51,460$141,396$83,226$110,774$42,024$61,497
Gross profit$196,075$223,317$203,255$144,712$220,058$186,726$182,726$521,816
R&D expense$322,296$233,419$490,095$322,991$261,433$340,513$358,608$371,953
SG&A expense$921,321$967,442$775,624$1.25M$1.24M$1.07M$1.14M$1.18M
Operating income-$1.93M-$1.61M-$2.96M-$2.19M-$2.07M-$1.84M-$2.08M-$1.76M
Interest expense$15,526$5,039$1,447$0$179,183$121,808$5,677$461
Pretax income-$1.95M-$1.61M-$2.96M-$2.19M-$2.24M-$2.31M-$2.42M-$1.76M
Net income-$1.95M-$1.61M-$2.96M-$2.19M-$2.24M-$2.31M-$2.42M-$1.76M
EBITDA-$1.92M-$1.47M-$2.83M-$2.18M-$2.05M-$1.73M-$2.00M-$1.73M
EPS (basic)-0.05-0.05—-0.07-0.09-0.10—-0.09
EPS (diluted)-0.05-0.05—-0.07-0.09-0.10—-0.09
Weighted avg. shares (diluted)38.02M37.06M—33.67M27.58M24.30M—20.63M
Banking
Net interest income——————-$329,947-$24,378
Balance sheet
Cash & equivalents$16,287$122,633$200,782$18,164$767,914$3.30M$227,689$28,891
Short-term investments——$150,000———$150,000—
Receivables$32,417$83,792$100,843$29,862$137,999$25,948$60,573$493,121
Inventory$314,818$451,334$538,366$605,390$578,293$529,342$323,504$353,307
Current assets$697,545$941,019$1.71M$1.38M$2.11M$4.40M$5.61M$1.23M
PP&E, net$447,559$447,089$448,881$463,630$482,885$487,618$766,874$770,267
Intangibles$20,000$20,000$20,509$20,967$21,624$22,494$23,725$25,104
Total assets$2.15M$2.67M$3.58M$4.38M$5.26M$6.89M$9.34M$3.11M
Current liabilities$2.26M$1.31M$1.38M$988,421$1.05M$3.12M$4.32M$2.94M
Total liabilities$2.31M$1.31M$1.38M$997,404$1.08M$3.16M$5.12M$3.81M
Shareholders' equity-$159,093$1.36M$2.20M$3.38M$4.18M$2.97M$4.22M-$694,781
Shares outstanding38.13M37.59M35.85M34.45M32.95M24.40M24.18M21.25M
Cash flow statement
Operating cash flow-$947,041-$965,779-$812,382-$1.47M-$2.19M-$1.63M-$1.23M-$961,216
Capital expenditure$14,305$12,370$0-$5,195——$21,204$23,632
Free cash flow-$961,346-$978,149-$812,382-$1.46M——-$1.25M-$984,848
Investing cash flow-$14,305-$12,370$0$5,195——-$521,204-$23,632
Financing cash flow$855,000$900,000$995,000$711,750-$348,081$4.71M$1.95M$887,500
Depreciation & amortization$13,836$134,671$135,207$14,059$17,661$117,890$75,976$30,695
Stock-based compensation$134,564$460,609$478,837$568,459$92,728$133,197$90,278$315,806

Free plan shows the latest 8 periods; Pro shows all 64 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.